Showing material events only. Routine administrative filings — bylaw amendments, technical fund updates, procedural FD disclosures — are filtered out so the front page stays signal-dense.
6-K
Periodic Interim
confidence 98%
filed 2026-07-28
This is Barclays PLC's Half-Year Financial Report for the period ended 30 June 2026, comprising condensed consolidated financial statements, notes, and management commentary. The document explicitly states "This Report comprises: Information given to The London Stock Exchange and furnished pursuant to General Instruction B to the General Instructions to Form 6-K" and is titled "Interim Results Announcement 30 June 2026." It includes full financial statements (income statement, balance sheet, cash flow), risk management disclosures, and director certifications—the hallmarks of a periodic interim financial report, not a discrete event or press release.
View raw filing on EDGAR →
6-K
Periodic Interim
confidence 95%
filed 2026-07-28
The 6-K furnishes a "Half-year Financial Report" dated 28 July 2026, explicitly labeled as "2026 Interim Results Announcement." This is a periodic interim financial report (the foreign-issuer equivalent of a 10-Q), not a discrete event. The filing announces submission of interim results to the National Storage Mechanism and provides access links, consistent with periodic reporting obligations under DTR 6.3.5R(1A).
View raw filing on EDGAR →
8-K
Operational Other
confidence 72%
filed 2026-07-28
Item 8.01
The filing discloses a comprehensive strategic update involving multiple initiatives: active pursuit of acquisitions and transformational transactions, divestiture of underperforming assets, and a detailed plan to address Nasdaq listing deficiencies through M&A, balance sheet strengthening, expense reduction, and a reverse stock split. While the disclosure touches on delisting risk (Nasdaq compliance measures), the primary focus is on the Company's operational and strategic repositioning—a shift toward disciplined capital allocation and portfolio optimization. This is best classified as an operational/strategic business event rather than a delisting-risk notice, as the Company is proactively disclosing its comprehensive remediation plan rather than reporting a delisting notice or failure to comply.
View raw filing on EDGAR →
6-K
Earnings release
confidence 95%
filed 2026-07-28
This is GSK's Q2 2026 financial results announcement, disclosing quarterly turnover of £8.4 billion (+5% CER), core operating profit growth of +7%, and core EPS growth of +9%. The document presents comprehensive financial performance metrics, segment results, and forward guidance for full-year 2026, which are hallmarks of a quarterly earnings release. Material to investors assessing the registrant's operational and financial performance.
View raw filing on EDGAR →
6-K
Operational Other
confidence 85%
filed 2026-07-28
GSK announces positive Phase III trial results (ARTEMIS-011) for Ris-Rez in relapsed osteosarcoma, meeting its primary endpoint of progression-free survival. This is a material clinical development milestone for a key oncology asset with FDA Breakthrough Therapy Designation, demonstrating efficacy across multiple tumor types and supporting GSK's broader development program. The disclosure is operational/strategic rather than a discrete financial event, earnings release, or executive action.
View raw filing on EDGAR →
6-K
Operational Other
confidence 85%
filed 2026-07-28
GSK announced a major strategic R&D investment and operational restructuring: establishment of a new £400 million flagship R&D centre in Cambridge over 3 years, relocation of over 1,000 scientists from Stevenage by 2029, and upgrades to Ware facilities. This is a material operational and strategic business event involving significant capital deployment and workforce repositioning, but does not fit the specific categories of M&A, workforce reduction (though it involves relocation), or other named types. It is clearly operational in nature and would affect a reasonable investor's assessment of GSK's R&D strategy and capital allocation.
View raw filing on EDGAR →
8-K
Debt Issuance
confidence 95%
filed 2026-07-28
Item 2.03
The Federal Home Loan Bank of New York discloses the issuance of consolidated obligation bonds and discount notes on specified trade dates in July 2026, totaling approximately $1.55 billion in principal across multiple securities with varying maturities (2027–2031) and rate structures. Item 2.03 explicitly covers "Creation of a Direct Financial Obligation," and the filing states that "consolidated obligations issuance is material to the Bank." Schedule A details specific bond issuances with CUSIPs, settlement dates, maturity dates, coupon rates, and principal amounts, confirming new debt creation.
View raw filing on EDGAR →
8-K
M&A activity
confidence 72%
filed 2026-07-28
Item 1.01
Kinetic Seas entered into a Third Addendum to its Licensing Agreement with Sagtec Global Limited on July 7, 2026, which modified material commercial terms including the return of 2,000,000 consideration shares, elimination of right of first refusal, and establishment of additional commercial arrangements. While this is technically an amendment to an existing agreement rather than a new M&A transaction, the modification of commercial arrangements and share transfer constitute a material modification to the parties' relationship that affects the registrant's capital structure and contractual obligations.
View raw filing on EDGAR →
8-K
Debt Issuance
confidence 85%
filed 2026-07-28
Item 2.03
Kinetic Seas entered into a Securities Purchase Agreement on July 8, 2026, issuing a 6% Convertible Redeemable Note with $210,000 principal amount and $189,000 gross proceeds, creating a new direct financial obligation with specified maturity, interest rate, redemption terms, and default provisions.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 92%
filed 2026-07-28
Item 3.02
Kinetic Seas conducted an unregistered sale of equity securities relying on Section 4(a)(2) and Rule 506 exemptions as part of the Securities Purchase Agreement, representing a material private placement to a private investor.
View raw filing on EDGAR →
8-K
Exec Compensation
confidence 95%
filed 2026-07-28
Item 5.02
The filing discloses compensatory arrangements approved by the Compensation Committee on July 24, 2026, including a warrant grant to CEO Dr. Allan Evans (5,000,000 shares at $25.00 exercise price, vesting upon stock price targets) and stock option grants to three executive officers (Andrew Camden, Brian Hoff, and Stacy Wright). The CEO's arrangement is particularly material as it involves a substantial equity grant coupled with a waiver of all cash compensation following December 31, 2026. This is a classic Item 5.02(e) disclosure of executive compensation arrangements.
View raw filing on EDGAR →
8-K
Operational Other
confidence 72%
filed 2026-07-28
Item 8.01
Chilean Cobalt Corp. disclosed that its Letter of Interest from the Export-Import Bank of the United States expired on July 22, 2026, and cannot be renewed under EXIM's guidelines. The company has submitted a new application for an LOI with substantially similar terms. This is a material operational/financing event because access to EXIM financing is critical for the company's business, and the disclosure acknowledges uncertainty about whether a new LOI will be issued or on what terms—creating potential financing risk. The event does not fit neatly into a specific category (debt_issuance, covenant_breach, or going_concern) because it concerns a financing application and contingent access to credit rather than a completed transaction or an existing obligation breach.
View raw filing on EDGAR →
6-K
M&A activity
confidence 92%
filed 2026-07-28
EX-99.1
VersaBank announced a special shareholder meeting scheduled for September 16, 2026, to vote on a proposed reorganization that will realign its corporate structure to a standard U.S. bank framework. The reorganization involves creating Versa Bancorp, a new Delaware corporation, as the direct holding company of VersaBank and VersaBank USA National Association, with Versa Bancorp succeeding VersaBank as the publicly traded company. This constitutes a material change of control and corporate restructuring requiring shareholder approval and regulatory approvals from the Canadian Minister of Finance and the U.S. Federal Reserve Board.
View raw filing on EDGAR →
8-K
Earnings release
confidence 98%
filed 2026-07-28
Item 2.02
Lemonade announced its financial results for Q2 and six months ended June 30, 2026 via a shareholder letter furnished as Exhibit 99.1. The disclosure includes comprehensive quarterly and year-to-date financial metrics (revenue, gross profit, net loss, adjusted EBITDA), key operating metrics (in-force premium, customer count, premium per customer), and forward guidance for Q3 and full-year 2026. This is a standard earnings release disclosure under Item 2.02.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 85%
filed 2026-07-28
Item 5.02
The filing discloses the appointment of Nick Stead as Chief Financial Officer effective January 1, 2027, along with his designation as principal financial officer and principal accounting officer. While the filing also mentions Tim Bixby's transition from CFO to Board member, the principal disclosed action centers on Stead's appointment to the CFO role, a named executive officer position. The appointment of a new CFO is material to investors assessing the company's financial leadership and governance.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 95%
filed 2026-07-28
Item 3.02
Carlyle Credit Solutions completed an unregistered sale of 2,904,955 shares of Class I common stock for $52.3 million in aggregate consideration under Section 4(a)(2) and Regulation D exemptions, increasing outstanding shares from approximately 95.5 million to 98.4 million.
View raw filing on EDGAR →
8-K
Dividend Distribution
confidence 95%
filed 2026-07-28
Item 7.01
The Board of Directors declared a cash dividend of $0.14 per share of Class I Common Stock, payable August 27, 2026 to shareholders of record as of July 31, 2026.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 75%
filed 2026-07-28
Item 8.01
The company disclosed an ongoing 'New Continuous Offering' of unregistered Class I Common Stock shares on a continuous basis, with 67.4 million shares issued for $1.3 billion in total consideration and stated intent to continue selling shares monthly.
View raw filing on EDGAR →
8-K
Earnings release
confidence 98%
filed 2026-07-28
Item 2.02
BrightSpire Capital issued a press release on July 28, 2026 announcing its financial results for the second quarter ended June 30, 2026, including GAAP net loss of ($18.3) million, Distributable Earnings of $15.8 million per share, and book value metrics. The Item 2.02 disclosure explicitly states the company "issued a press release announcing its financial position as of June 30, 2026 and its financial results for the second quarter ended June 30, 2026," with the press release attached as Exhibit 99.1, which is the standard format for quarterly earnings releases.
View raw filing on EDGAR →
8-K
Earnings release
confidence 98%
filed 2026-07-28
Item 2.02
This is a clear earnings release for Q2 2026 financial results. The Item 2.02 disclosure states "Kiniksa Pharmaceuticals International, plc issued a press release announcing financial results for the quarter ended June 30, 2026," and the attached exhibit (EX-99.1) is the full press release reporting Q2 2026 financial results including total revenue of $243.6 million, operating expenses of $216.4 million, and net income of $25.4 million, along with updated 2026 ARCALYST revenue guidance of $980-$995 million. This is material to investors as it discloses quarterly financial performance and updated full-year guidance.
View raw filing on EDGAR →
6-K
Shareholder vote
confidence 95%
filed 2026-07-28
EX-99.1
This exhibit announces the results of an extraordinary general meeting held on July 28, 2026, where shareholders voted on five resolutions: (1) change of company name, (2) increase of authorized share capital from US$250,000 to US$31,250,000, (3) share consolidation at a 1-for-5 to 1-for-10 ratio, (4) redesignation of 182,983 Class A shares to Class B shares, and (5) omnibus resolutions. The filing explicitly provides voting tabulations for each resolution, including votes in favor, against, and abstained/withheld. These capital structure changes—particularly the 125-fold increase in authorized capital and the discretionary share consolidation—are material to investors' assessment of ownership dilution and voting power.
View raw filing on EDGAR →
8-K
Earnings release
confidence 98%
filed 2026-07-28
Item 2.02
Carrier Global Corporation issued a press release on July 28, 2026, announcing its second quarter 2026 financial results, including net sales of $6.4 billion (up 4%), GAAP EPS of $0.60, adjusted EPS of $0.86, and free cash flow of $810 million. The company also raised its full-year 2026 outlook to approximately $23 billion in sales and $2.90 adjusted EPS. This is a standard quarterly earnings disclosure furnished as Exhibit 99 under Item 2.02.
View raw filing on EDGAR →
8-K
Material Litigation
confidence 95%
filed 2026-07-28
Item 7.01
Judge Denise Cote of the U.S. District Court for the Southern District of New York entered an Opinion and Order awarding $719 million in disgorgement of unjust profits plus attorney's fees and costs to Skillz Platform Inc. (Firy's subsidiary) in a false advertising lawsuit against Papaya Gaming under the Lanham Act and New York General Business Law. This is a material litigation settlement/judgment that materially affects the registrant's financial position and would significantly influence a reasonable investor's assessment of the company.
View raw filing on EDGAR →
8-K
Other material
confidence 65%
filed 2026-07-28
Item 8.01
Joby Aviation disclosed a warrant expiration notice for 14.2 million outstanding warrants (CUSIP G65163 118) expiring August 10, 2026, with trading suspension on August 7, 2026. While this is a routine administrative reminder about an existing security's maturity, the materiality stems from the significant number of warrants outstanding and the potential dilutive impact if exercised at the $11.50 strike price. This does not fit neatly into a specific category—it is neither a dilutive issuance (no new securities being issued), nor a dividend, nor a governance matter, but rather a capital structure event affecting warrant holders' rights.
View raw filing on EDGAR →
8-K
Exec departure
confidence 95%
filed 2026-07-28
Item 5.02
Andrew Winn, Chief Financial Officer, resigned effective August 4, 2026, due to personal reasons. The principal disclosed action is a named executive officer leaving his position. While the filing mentions a severance payment of $84,057.53 for accrued PTO, the core event is the departure itself, not a compensatory arrangement. The CFO role is material to investor assessment of the company's financial oversight and governance.
View raw filing on EDGAR →
8-K
M&A activity
confidence 98%
filed 2026-07-28
Item 8.01
Leonardo DRS announced entry into a definitive agreement to acquire Raft LLC in an all-cash transaction valued at $450 million. The press release explicitly states the company "has entered into a definitive agreement to acquire Raft LLC" and describes the strategic rationale, expected timing (Q4 2026), financing approach, and anticipated financial benefits (accretion and ~$50M tax benefit). This is a material acquisition that would significantly affect investor assessment of the company's strategy and financial position.
View raw filing on EDGAR →
8-K
Delisting risk
confidence 92%
filed 2026-07-28
Item 1.02
The filing discloses that Nuvve's common stock was delisted from Nasdaq effective July 24, 2026, triggering automatic termination of a $25 million committed equity facility (ELOC Agreement). While Item 1.02 nominally addresses termination of a material agreement, the salient event is the delisting itself—a terminal listing event that materially impairs the company's access to capital markets and signals substantial financial distress. The delisting is the triggering cause and the primary material disclosure.
View raw filing on EDGAR →
8-K
Dilutive issuance
confidence 95%
filed 2026-07-28
Item 3.02
Core Scientific issued a warrant to AMD to purchase up to 30 million shares of common stock at $23.47 per share, with approximately 6.5 million shares vesting immediately upon execution of leases on July 27, 2026, in reliance on Section 4(a)(2) of the Securities Act.
View raw filing on EDGAR →
8-K
Operational Other
confidence 85%
filed 2026-07-28
Item 7.01
Core Scientific entered into material lease agreements with AMD (377 MW) and Neocloud (152 MW) for critical IT capacity across multiple data center sites with 15-year terms and options to expand to 2.5 gigawatts, representing a significant strategic partnership and operational expansion.
View raw filing on EDGAR →
8-K
Earnings release
confidence 97%
filed 2026-07-28
Item 2.02
Core Scientific issued a press release on July 28, 2026 announcing Q2 2026 financial results for the quarter ended June 30, 2026, disclosing quarterly revenue of $164.2 million, gross profit of $70.0 million, net loss of $1,155.3 million (driven by warrant fair value changes), and adjusted EBITDA of $41.1 million, along with condensed consolidated financial statements and operating metrics.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 95%
filed 2026-07-28
Item 5.02
The filing discloses the appointment of five executive officers effective July 27, 2026: Alexandra Renner (Chief Product Officer), John Hanson (Chief of Staff), Vivek Narayanadas (General Counsel and Corporate Secretary), Erik Lassen (Senior Vice President of Engineering), and Michael Dixon (Vice President of Accounting and Controller/Principal Accounting Officer). While some appointees were already serving in these roles informally, the Board's formal appointment of these individuals to executive officer positions on July 22, 2026 constitutes a material governance event affecting the registrant's leadership structure and disclosure obligations.
View raw filing on EDGAR →
8-K
Debt Issuance
confidence 92%
filed 2026-07-28
Item 1.01
Galaxy Digital completed a private offering of $3.507 billion in 9.875% Senior Secured Notes due 2031 on July 28, 2026. The notes carry detailed covenants and redemption provisions, with proceeds designated to finance a major data center project in Texas.
View raw filing on EDGAR →
8-K
Exec departure
confidence 92%
filed 2026-07-28
Item 5.02
Rick Dunn's resignation as CFO, effective August 21, 2026, is the principal disclosed action. While the filing also mentions a potential interim appointment of Dustin Greer, the core event is Dunn's departure following a mutual agreement and transition period. CFO departures are material to investors assessing management continuity and financial leadership.
View raw filing on EDGAR →
8-K
Earnings release
confidence 92%
filed 2026-07-28
Item 2.02
HF Sinclair issued a press release on July 28, 2026 announcing second quarter 2026 financial results, including net income of $892 million ($4.93 per diluted share) and adjusted net income of $960 million ($5.31 per diluted share), along with segment performance metrics, EBITDA figures, and a 5% dividend increase.
View raw filing on EDGAR →
8-K
Going Concern
confidence 95%
filed 2026-07-28
Item 8.01
The auditor's report explicitly states "substantial doubt about the Company's ability to continue as a going concern," citing the SPAC's need to obtain necessary approvals and raise additional capital to fund operations and complete a business combination within 12 months. This is the unmistakable language required for going_concern classification and is material to investors evaluating the registrant's viability.
View raw filing on EDGAR →
8-K
Earnings release
confidence 98%
filed 2026-07-28
Item 2.02
Crane Company disclosed its second quarter 2026 financial results on July 28, 2026, including net sales of $724.7 million (up 25.6% YoY), diluted EPS of $1.63 (up 19%), and adjusted EPS of $1.79 (up 18%), along with a raised full-year adjusted EPS guidance to $6.85–$7.05. The press release and quarterly financial data supplement are furnished as Exhibit 99.1, which is the standard format for earnings releases under Item 2.02.
View raw filing on EDGAR →
8-K
Earnings release
confidence 99%
filed 2026-07-28
Item 2.02
Veralto issued a press release on July 28, 2026 announcing financial results for the quarter ended July 3, 2026, disclosing Q2 2026 sales of $1,474 million (7.6% YoY growth), net earnings of $241 million ($0.98 per diluted share), and raising full-year 2026 adjusted EPS guidance to $4.35–$4.43. This is a standard quarterly earnings release filed under Item 2.02 with the press release furnished as Exhibit 99.1.
View raw filing on EDGAR →
8-K
Earnings release
confidence 97%
filed 2026-07-28
Item 2.02
Western New England Bancorp disclosed quarterly and six-month financial results for the period ended June 30, 2026, reporting net income of $3.6 million ($0.18 per diluted share) for Q2 2026 and $8.4 million ($0.42 per diluted share) for the six-month period, along with a declaration of a quarterly cash dividend of $0.07 per share.
View raw filing on EDGAR →
6-K
Earnings release
confidence 95%
filed 2026-07-28
This is a quarterly earnings announcement for Q2 2026 disclosing consolidated financial and operating results for OMA, including passenger traffic (7.2 million, +0.4%), revenue growth (+5.4%), Adjusted EBITDA (+6.2% to Ps.2,722 million), and net income (+10.2% to Ps.1,478 million). The document explicitly states "OMA Announces Second Quarter 2026 Operating and Financial Results" and includes detailed financial metrics, cash flow statements, and earnings per share (Ps.3.80), which are hallmarks of a quarterly earnings release.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 95%
filed 2026-07-28
Item 5.02
Terrestrial Energy Inc. appointed Kathryn McCarthy to its Board of Directors effective July 22, 2026. McCarthy brings substantial nuclear industry expertise, including leadership of the US ITER Project and senior roles at national laboratories, strengthening the company's governance in advanced reactor development.
View raw filing on EDGAR →
6-K
Dividend Distribution
confidence 95%
filed 2026-07-28
EX-99.1
The exhibit is a press release announcing that Titan America's Board of Directors has declared a distribution of $0.04 per common share for Q3 2026 payable on October 9, 2026, to shareholders of record as of October 1, 2026. Although the distribution is characterized as being paid "out of Titan America's available issue premium" rather than from earnings, it is a return of capital to shareholders and constitutes a dividend or distribution event material to investors assessing the company's capital allocation and shareholder returns.
View raw filing on EDGAR →
6-K
Earnings release
confidence 98%
filed 2026-07-28
EX-99.1
This is a press release announcing Titan America's second quarter 2026 financial results, including revenue of $470.6 million (up 9.6% YoY), net income of $43.3 million, and adjusted EBITDA of $100.7 million. The document contains condensed consolidated financial statements, segment performance analysis, and updated full-year 2026 outlook. This is a discrete earnings announcement, not a periodic financial report filing, and would materially affect investor assessment of the company's financial performance and acquisition integration progress.
View raw filing on EDGAR →
8-K
Earnings release
confidence 98%
filed 2026-07-27
Item 2.02
Cincinnati Financial Corporation disclosed second-quarter 2026 financial results via a news release titled "Cincinnati Financial Reports Second-Quarter 2026 Results" furnished as Exhibit 99.1. The disclosure includes net income of $1.255 billion ($8.05 per share) for Q2 2026 versus $685 million ($4.34 per share) for Q2 2025, along with comprehensive financial tables, segment results, and management commentary on operations and performance. This is a standard quarterly earnings release under Item 2.02.
View raw filing on EDGAR →
8-K
Auditor Change
confidence 98%
filed 2026-07-27
Item 4.01
The Company dismissed Ernst & Young LLP as its independent registered public accounting firm on July 23, 2026, due to independence concerns arising from the announced Merger Agreement involving AES and Horizon Parent. KPMG LLP was simultaneously engaged as the new auditor effective upon EY's dismissal. This is a classic auditor change under Item 4.01, with clear disclosure of the prior auditor's dismissal and the new auditor's appointment, along with confirmatory statements regarding the absence of disagreements or reportable events.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 95%
filed 2026-07-27
Item 5.02
Nathan E. Tagg was appointed to the Board of Directors of Independent Bank Corporation, effective July 21, 2026, following the company's acquisition of HCB Financial Corp. on July 1, 2026. The Board was expanded from 10 to 11 members to accommodate his appointment, and he was also appointed to the Audit Committee. This is a clear executive appointment event, material to investors as it reflects post-acquisition board integration and governance changes.
View raw filing on EDGAR →
8-K
Exec departure
confidence 75%
filed 2026-07-27
Item 5.02
John Hight, President of Wizards of the Coast, is transitioning out of his current role effective September 1, 2026, and will move to an advisory position for one year. While the agreement includes compensatory arrangements (base salary continuation, bonus eligibility, equity vesting), the principal disclosed action is his departure from the President role and planned transition, making this fundamentally an executive departure event. The material nature is supported by his senior position and the structured transition arrangement.
View raw filing on EDGAR →
8-K
Earnings release
confidence 98%
filed 2026-07-27
Item 2.02
UDR issued a press release on July 27, 2026, announcing its second quarter 2026 financial results, including Net Income, FFO, and FFOA per diluted share, along with Same-Store operating metrics and raised full-year 2026 guidance. The filing explicitly states this is Item 2.02 (Results of Operations and Financial Condition) with the press release furnished as Exhibit 99.1, which is the standard format for quarterly earnings disclosures.
View raw filing on EDGAR →
8-K
M&A activity
confidence 85%
filed 2026-07-27
Item 8.01
PLP Canada, a subsidiary of Preformed Line Products Company, acquired a facility and related land for approximately CAD 23.5 million ($16.7 million) on July 21, 2026. Although disclosed under Item 8.01 (Other Events) rather than the typical Item 1.01 or 2.01, this constitutes a material acquisition of a property asset intended to expand manufacturing capacity and support growth. The transaction size and strategic purpose (capacity expansion) make it material to investors.
View raw filing on EDGAR →
8-K
Material Litigation
confidence 95%
filed 2026-07-27
Item 7.01
Johnson & Johnson announced a comprehensive settlement agreement for ovarian talc litigation with a $5.5 billion commitment, resolving approximately 76,000 remaining claims. This represents a material settlement of long-standing product liability litigation that would significantly affect investor assessment of the company's financial obligations and legal exposure. The settlement follows a favorable MDL court ruling on causation but constitutes a major resolution of a 15-year litigation matter.
View raw filing on EDGAR →
8-K
Earnings release
confidence 98%
filed 2026-07-27
Item 2.02
This Item 2.02 discloses Peoples Bancorp's results of operations for the quarter and six months ended June 30, 2026, presented through a management conference call held on July 21, 2026. The filing includes detailed financial tables reconciling non-GAAP measures to GAAP results, earnings per share data ($0.78 diluted EPS reported, $0.96 adjusted), net income of $27.953 million for Q2, and forward guidance on net interest margin, fee-based income, and expenses. The conference call transcript (Exhibit 99.1) contains management commentary on financial performance, loan growth, deposit trends, and capital ratios—all hallmarks of a quarterly earnings release disclosure under Item 2.02.
View raw filing on EDGAR →